Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients

Larry Beresford  |  Issue: December 2017  |  December 17, 2017

All rheumatologists have observed the impact of their patients’ mental health status on the long-term treatment of rheumatologic conditions. Depression, anxiety and even loneliness can lead to poor clinical outcomes and nonadherence to treatment, whether the patient is following medication regimens or participating in regular exercise. On the other hand, a patient’s resilience and positive attitude will aid in chronic disease management.

Research has confirmed these links between rheumatologic conditions and psychological comorbidities. But what can practicing rheumatologists do with this information? They are not likely to become experts in psychology or start providing cognitive-behavioral therapy for patients struggling to cope. But there are things rheumatologists can do, depending on the structure of their practice and its relationship with other providers. Some of the better models come from Europe, where much of the research has been done and where medical psychologists often are better integrated into hospitals and medical practices.

Dr. Lee

Dr. Lee

“What we’re talking about is a clear association between psycho-social conditions and rheumatic disease, even though there’s not an obvious chicken-and-egg causality,” says Yvonne C. Lee, MD, rheumatologist at Brigham and Women’s Hospital, Boston. Sometimes, one might trigger the other, but it can go either way. “Rheumatologists should be aware [that] depression is common among rheumatology patients and [be] alert for it in their own patients. If they note symptoms of depression, it is imperative to make sure it gets appropriately evaluated and managed,” Dr. Lee says.

“Although it’s not necessarily [the] rheumatologist’s job to treat depression, they should acknowledge the problem, discuss the issues with their patients and make a plan for further evaluation and management through the patient’s primary care physician—or refer [the patient] to a specialist.” It would help to have access to a medical psychologist if the health system can facilitate such a referral, she says, but a broad range of other healthcare workers also deal with psycho-social issues, from social workers to psychologists to psychiatrists.

Dr. Hassett

Dr. Hassett

Health professionals use the term psychiatric comorbidities to describe the simultaneous presence of anxiety or depression with rheumatologic conditions, notes clinical psychologist Afton Hassett, PsyD, associate research scientist in anesthesiology at the University of Michigan, and immediate past president of the ARHP. Dr. Hassett studies the impact of cognitive and affective factors in clinical pain conditions, such as RA, fibromyalgia and lupus. “These comorbidities are extremely common, and they further interact with chronic pain, all of which impact how a person lives,” she says.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsPain SyndromesPractice Support Tagged with:anxiety disordersbehaviorcognitivecomorbiditiesDepressionfatigueFibromyalgiaLupusManagementMental Healthpatient carepsychologicalquality of lifeRARheumatoid arthritisrheumatologic conditionsrheumatologistrheumatologySLEtherapyTreatment

Related Articles

    7 Tools to Identify Depression

    August 1, 2014

    Why screening for depressive symptoms in patients with arthritis is needed

    Depression in Rheumatoid Arthritis

    November 1, 2012

    Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

    Depression & Anxiety Linked to Poor Rheumatoid Arthritis Outcomes

    September 18, 2015

    NEW YORK (Reuters Health)—Rheumatoid arthritis patients with depression and anxiety symptoms may have worse outcomes and poorer response to prednisolone, a secondary analysis of the CARDERA trial has found. “The strength of association between depression/anxiety and disease activity outcomes and treatment response warrants routine screening,” the study’s lead author Faith Matcham at King’s College London…

    Targeted Rheumatoid Arthritis Treatment Does Not Improve Mental Health

    June 14, 2018

    NEW YORK (Reuters Health)—Effective pharmacotherapy of rheumatoid arthritis (RA) is not associated with meaningful improvements in mental health, according to a systematic review and meta-analysis. “We were surprised by the small effect sizes for mental-health outcomes across all of the treatments included in this review, but particularly for the anti-TNF versus disease-modifying antirheumatic drug (DMARD)…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences